Increased frequency of pre-germinal center b cells and plasma cell precursors in the blood of children with systemic lupus erythematosus

Journal of Immunology

Volumn 167, Issue 4, 2001, Pages 2361-2369

  Arce, E ^a   Jackson, D G ^a   Gill, M A ^a   Bennett, L B ^a   Banchereau, J ^a   Pascual, V ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CYCLOPHOSPHAMIDE; DNA; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PREDNISONE; RNA;

ARTICLE; B LYMPHOCYTE; CHILD; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; LUPUS ERYTHEMATOSUS; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MEMORY CELL; PLASMA CELL; PRIORITY JOURNAL; STEM CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0035881627     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.4.2361     Document Type: Article

References (63)

1. Expansion of pregerminal center B cells in the blood of pediatric Sle patients
2. Altered B cells and dendritic cells in SLE
3. Lymphopenia in systemic lupus erythematosus: Clinical, diagnostic, and prognostic significance
4. Inquiry into murine and human lupus
5. The central and multiple roles of B cells in lupus pathogenesis
6. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity
7. The role of B cells in lpr/lpr-induced autoimmunity
8. The roles of B cells in MRL/lpr murine lupus
9. 1 mice
10. Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus
11. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus
12. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events
13. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients
14. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production
15. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus
16. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera
17. The soluble CD40 ligand sCD154 in systemic lupus erythematosus
18. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development
19. Germinal center development
20. - germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts
21. CD27: A memory B-cell marker
22. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells
23. Recombinant 25-kDa CD23 and interleukin 1α promote the survival of germinal center B cells: Evidence for bifurcation in the development of centrocytes rescued from apoptosis
24. Human follicular dendritic cells enhance cytokine-dependent growth and differentiation of CD40-activated B cells
25. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation
26. Memory B cells are biased towards terminal differentiation: A strategy that may prevent repertoire freezing
27. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. I. The architecture and dynamics of responding cell populations
28. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells
29. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance
30. Clonal selection and learning in the antibody system
31. A comparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus
32. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus
33. Analysis of somatic mutation in five B cell subsets of human tonsil
34. Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes
35. IMGT, the international Immunogenetics database
36. Reference ranges for lymphocyte subsets in pediatric patients
37. Immunophenotyping of blood lymphocytes in childhood: Reference values for lymphocyte subpopulations
38. Identification of centerin, a novel human germinal center B cell-restricted serpin
39. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation
40. Identification of early plasma cells in peripheral blood and their clinical significance
41. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells
42. Regulation of CD27 expression in the course of germinal center B cell differentiation: The pivotal role of IL-10
43. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus
44. Anti-lymphocytic antibody and autoimmune disease: A review
45. Lymphocytotoxic antibodies in SLE: A review of the literature
46. Spontaneous and induced apoptosis in systemic lupus erythematosus: Multiple assays fail to reveal consistent abnormalities
47. Bone marrow findings in connective tissue disease
48. The acute lupus hemophagocytic syndrome
49. Systemic lupus erythematosus presenting with myelofibrosis
50. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype
51. Serum levels of interferons in patients with systemic lupus erythematosus
52. Interferon-induced 2′-5′ adenylate synthetase in vivo and interferon production in vitro by lymphocytes front systemic lupus erythematosus patients with and without circulating interferon
53. MX homologous protein in mononuclear cells front patients with systemic lupus erythematosus
54. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy
55. Impairment of T and B cell development by treatment with a type I interferon
56. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4
57. Lupus and interleukin 10
58. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus
59. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus
60. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
61. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice
62. Blys: Member of the tumor necrosis factor family and B lymphocyte stimulator
63. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease